Multiple myeloma: biological and clinical significance of bone marrow plasma cell labelling index
Boccadoro, M.; Massaia, M.; Dianzani, U.; Pileri, A.
Haematologica 72(2): 171-175
1987
ISSN/ISBN: 0390-6078 PMID: 3114074 Document Number: 292445
Document emailed within 1 workday
Related Documents
Hantaweepant, C.; Chinthammitr, Y.; Khuhapinant, A.; Sukpanichnant, S. 2016: Clinical Significance of Bone Marrow Involvement as Confirmed by Bone Marrow Aspiration vs. Bone Marrow Biopsy in Diffuse Large B-cell Lymphoma Journal of the Medical Association of Thailand 99(3): 262-269Pasqualetti, P.; Colantonio, D.; Casale, R. 1990: Prognostic value of the ratio of bone marrow plasma cells in multiple myeloma Minerva Medica 81(3): 129-133
Rhodes, E.G.; Baker, P.K.; Duguid, J.K.; Davies, J.M.; Cawley, J.C. 1992: A method for clinical purging of myeloma bone marrow using peanut agglutinin as an anti-plasma cell agent, in combination with CD19 monoclonal antibody Bone Marrow Transplantation 10(6): 485-489
Lopes da Silva, R.; Costa, I.; Prata, M.; Sousa, A.Botelho. 2011: Plasma cell meningitis: a rare neurological complication of multiple myeloma requiring a high index of suspicion Acta Neurologica Taiwanica 20(3): 209-212
Kang, H.Y.; Wang, C.B. 2016: The significance of clinical-examination communication in the total process of bone marrow cell morphology and bone marrow biopsy Zhonghua Yi Xue Za Zhi 96(24): 1884-1887
Kara, I.Oguz.; Sahin, B.; Gunesacar, R.; Unsal, C. 2006: Clinical significance of hepatocyte growth factor, platelet-derived growth factor-AB, and transforming growth factor-alpha in bone marrow and peripheral blood of patients with multiple myeloma Advances in Therapy 23(4): 635-645
Dmoszyńska, A.; Podhorecka, M.; Roliński, J.; Soroka-Wojtaszko, M. 2004: Influence of lovastatin on BCL-2 and BAX expression by plasma cells and T lymphocytes in short-term cultures of multiple myeloma bone marrow mononuclear cells Polish Journal of Pharmacology 56(4): 485-489
Büchi, G.; Girotto, M.; Veglio, M.; Clerico, M.; Gario, S.; Termine, G.; Autino, R. 1990: Kappa/lambda ratio on peripheral blood lymphocytes and bone marrow plasma cell labeling index in monoclonal gammopathies Haematologica 75(2): 132-136
Duncan, N.; Hewetson, M.; Powles, R.; Raje, N.; Mehta, J. 1996: An economic evaluation of peripheral blood stem cell transplantation as an alternative to autologous bone marrow transplantation in multiple myeloma Bone Marrow Transplantation 18(6): 1175-1178
Ng, A.P.; Wei, A.; Bhurani, D.; Chapple, P.; Feleppa, F.; Juneja, S. 2006: The sensitivity of CD138 immunostaining of bone marrow trephine specimens for quantifying marrow involvement in MGUS and myeloma, including samples with a low percentage of plasma cells Haematologica 91(7): 972-975
Gahrton, G. 1999: Allogeneic bone marrow transplantation in multiple myeloma Pathologie-Biologie 47(2): 188-191
Rizzo, M.; Meli, C.; Bonanno, M.; Maccarrone, S.; Guglielmo, P. 1981: Bone marrow T-lymphocyte subpopulations in patients with multiple myeloma Bollettino della Societa Italiana di Biologia Sperimentale 57(6): 678-684
Kurtova, A.V.; Sivachenko, E.B.; Utkina, L.A.; Slobodniuk, K.Iu.; Stepanova, N.V.; Iakubovich, M.A.; Moiseev, S.I.; Zueva, E.E. 2008: Bone marrow immunophenotyping for the diagnosis of multiple myeloma: practical aspects Klinicheskaia Laboratornaia Diagnostika 2008(1): 17-20
Commes, T.; Clofent, G.; Ghanem, N.; Zhang, X.G.; Lefranc, M.P.; Bataille, R.; Klein, B. 1993: Analysis of the B-cell compartment in plasma cell leukemia and multiple myeloma: immunoglobulin gene rearrangement of EBV-infected B-cell lines Leukemia 7(4): 609-617
Kurihara, K.; Hill, W.; Burkhardt, R.; Kettner, G.; Hashimoto, N. 1987: Bone marrow changes following chemotherapy for multiple myeloma--a clinicopathological study of biopsy cases Nihon Ketsueki Gakkai Zasshi: Journal of Japan Haematological Society 50(4): 876-889
Okubo, H.; Inoue, T.; Kudo, J.; Okumura, Y.; Hayashida, K. 1985: Impaired synthesis of polyclonal immunoglobulin by bone marrow cells in a patient with multiple myeloma Nihon Ketsueki Gakkai Zasshi: Journal of Japan Haematological Society 48(4): 1083-1089
Mamaev, N.N.; Mamaeva, S.E.; Ushakova, E.A.; Liburkina, I.L.; Pozniak, E.I. 1986: Results of the study of the activity of bone marrow nucleolar organizers in patients with multiple myeloma Tsitologiia i Genetika 20(2): 91-97
Kraj, M.; Owczarska, K.; Sokołowska, U.; Centkowski, P.; Pogłód, R.; Kruk, B. 2005: Correlation of osteoprotegerin and sRANKL concentrations in serum and bone marrow of multiple myeloma patients Archivum Immunologiae et Therapiae Experimentalis 53(5): 454-464
Vescio, R.A.; Han, E.J.; Schiller, G.J.; Lee, J.C.; Wu, C.H.; Cao, J.; Shin, J.; Kim, A.; Lichtenstein, A.K.; Berenson, J.R. 1996: Quantitative comparison of multiple myeloma tumor contamination in bone marrow harvest and leukapheresis autografts Bone Marrow Transplantation 18(1): 103-110
Ceneli, O.; Haznedar, R. 2008: Advanced multiple myeloma with negative bone marrow biopsy and positive soft tissue lesions in the (18)F-FDG PET/CT scan Hellenic Journal of Nuclear Medicine 11(1): 56-57